|
|
| Curriculum vitae |
 |
:: LANGUAGES
...........................................................................................
|
French: Mother tongue.
English: Fluent.
|
:: PROFESSIONAL
EXPERIENCE
...........................................................................................
|
|
2000-Present
Independent medical and scientific translator
(English to French) and editor (French). President,
founder and webmaster of SciDocs Inc. See who
is using my services.
- English to French translation and editing of various scientific
and medical documents, including research papers, information
materials, newsletters and educational presentations.
- English to French translation and editing of pharmaceutical
documents, including product monographs, information sheets,
marketing material, and corporate sales training presentations.
- Responsible for ensuring level of material is appropriately
targeted to the audience (patients, health care professionals,
research scientists).
- Responsible for the accuracy of translated materials, both
from a linguistic and a scientific/medical point of view.
2004-2005
Consultant, Medical Radiation Sciences Program, The
University of Toronto/The Michener Institute. Project Manager
of the Teaching Enrichment Network Project. Please contact
me for more information on this project.
2000-2005
Freelance biotechnology instructor for the Applied
Biotechnology program, a distance education program of The
Michener Institute for Applied Health Sciences.
- Designed, developed and taught 7 new courses for the program:
Nucleic Acid Research, Bioinformatics, Proteomics, Peptide
Chemistry, Flow cytometry, Tissue and Cell Culture, Virology.
- Offsite and onsite teaching of the corresponding courses
to post-graduate students.
- Responsible for the conception of course assignments and
the design of courses for Web based learning.
- Responsible for evaluation of student progress and achievement.
|
:: EDUCATION
...........................................................................................
|
1999: Ph.D. Cellular and Molecular Biology,
Université Pierre et Marie Curie, Paris, France.
- Hôpital St-Antoine - INSERM U515 France
- Institut CURIE France
- The Hospital for Sick Children Toronto, Canada
- Institut d'Embryologie du CNRS et du Collège de France
France
1994: M.Sc. Cellular and Molecular Biology, Université
Pierre et Marie Curie, Paris, France. Rank: 3rd/21
- Institut CURIE France
- University of Cambridge Cambridge, United Kingdom
1993: B.Sc. Biochemistry, Université Denis Diderot,
Paris, France.
|
:: ASSOCIATIONS
AND MEMBERSHIPS
...........................................................................................
|
American Translators Association
Association of Translators and Interpreters of Ontario
Editors' Association of Canada
|
:: SCIENTIFIC
PUBLICATIONS AND COMMUNICATIONS
...........................................................................................
|
Chevalier, G, Yeger, H, Martinerie, C, Laurent,
M, Alami, J, Schofield, PN, Perbal, B: novH: Differential expression
in developing kidney and Wilms' tumors. Am J Path 1998, 152(6):1563-1575.
Chevalier, G, Perbal, B: Genetic alterations associated with
pathologic differentiation of Wilms' tumors. Bull Cancer 1997,
84:289-303.
Martinerie, C, Chevalier, G, Rauscher, FJr, Perbal, B: Regulation
of nov by WT1: a potential role for nov in nephrogenesis. Oncogene
1996, 12:1479-1492.
- - - - -
Chevalier, G., Palmer, C., Wiljer, D., Catton, P. Improving
The Lines of Communication in the Medical Radiation Sciences
Program: The first step towards a teaching enhancement network.
ISRRT 14th World Congress. Denver, USA. 9-13 June 2006.
Perbal B., Yeger H., Chevalier G., Laurent M., Martinerie C.,
Alami J., Schofield PN and Sainson R. The nephroblastoma overexpressed
(nov) protein: relationship with signaling, cell growth and
differentiation. 10th anniversary of the American Association
for Cancer Research Special Conferences, Gene Regulation and
Cancer. Hot Springs, USA. 14-18 October 1998.
Martinerie C., Chevalier G., Laurent M., Yeger H., Alami J.,
Schofield PN. and Perbal B. NOV: a putative new regulator of
cell growth and differentiation. EMBL Conference, Oncogenes
and growth control. Heidelberg, Allemagne. 18-22 April 1998.
Yeger H., Chevalier G., Alami J., and Perbal B. Expression of
novH in human rhabdomyosarcoma. 89th annual meeting of American
Association for Cancer Research. New Orleans, USA. 28 March-1
April 1998.
Laurent M., Chevalier G., Martinerie C., Pardanneau L., Barbot
W., Dieterlein F, and Perbal B. Regulation of the nov proto-oncogene
expression during normal chondrogenesis: a new approach in the
study of pathological limb development. 89th annual meeting
of American Association for Cancer Research. New Orleans, USA.
28 March-1 April 1998.
Chevalier G. Yeger H., Martinerie C., Laurent M., Kocialkowski
S., Schofield PN, and Perbal B. Nov: a new marker of Wilms'
tumor differentiation. 88th annual meeting of American Association
for Cancer Research. San Diego, USA. 12-16 April 1997.
Khelifi C., Chevalier G., Joliot V., Lasserre F., Cherel Y.,
Dambrine G., Wyers M., and Perbal B. Identification of LTR sequences
required for nephroblastoma induction by myeloblastosis associated
virus. The 8th Workshop on the pathogenesis of animal viruses.
Saint-Malo, France. 23-25 October 1996.
Perbal B., Chevalier G., Wyers M., Martinerie C., Pardanaud
L., Cherel Y., Schofield PN., Kocialkowski S., Dieterlen F.
and Dambrine G. Spatial and temporal expression of the antiproliferative
nov gene during normal and pathological organogenesis. 87th
Annual Meeting of the American Association for Cancer Research.
Washington, USA. 20-24 April 1996.
Chevalier G., Martinerie C., Schofield PN. et Perbal B. Expression
du gne novH dans les tumeurs de Wilms. XVme Forum de Cancrologie.
Paris, France. 12--14 June 1995.
Perbal B., Joubert I., Khelifi C., Joliot V., Chevalier G.,
Martinerie C., Scholz G., Hanafusa H., Schofield PN., and Dambrine
G. Pathogenic potential and cellular targets of Myeloblastosis
Associated Virus type 1 (N). 6th Workshop on the Pathogenesis
by Non-acutate Retroviruses. Philadelphia, USA. 3-5 December
1994.
Martinerie C., Chevalier G., Schofield PN. , Huff V., Rauscher
III FJ., and Perbal B. Downregulation of the human nov proto-oncogene
promoter activity by the Wilms tumor gene product. 10th Annual
Meeting on Oncogenes, NCI-NIH. Frederick, USA. 21-25 June 1994.
Martinerie C., Chevalier G., Schofield PN., Huff V., Rauscher
III FJ., Middendorp S., and Perbal B. Structural analysis of
the human nov proto-oncogene and expression in Wilms tumors.
Conférences Jacques Monod "Facteurs de croissance et
Matrice Extracellulaire". Aussois, France. 15-20 May 1994.
Schofield PN., Zumkeller W., Mahmood A., Chevalier G., Martinerie
C., and Perbal B. Insulin-like growth factors and their binding
proteins in the control of tumour cell growth. Eurocancer. Paris,
France. 26-29 April 1994.
|
|
|
|
|
